Travis Engelman

Travis Engelman possesses extensive experience in business development, mergers and acquisitions, and strategic management within the biotechnology and life sciences sectors. Currently serving as Vice President of M&A Business Development & Strategy for Danaher Corporation's Biotechnology Group, Travis leads strategic initiatives for a $4.4 billion platform. Previous roles include Director of Corporate Development at Thermo Fisher Scientific, where leadership of a team focused on M&A and partnerships took place, and Global Strategic Product Manager at Novartis, overseeing new product development and market assessments. An MBA graduate from the University of California, Davis, Travis's early career also includes successful positions in sales and marketing at Merck & Co. and Align Technology.